Clinical Trials Logo

Eustachian Tube Dysfunction clinical trials

View clinical trials related to Eustachian Tube Dysfunction.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05998356 Not yet recruiting - Clinical trials for Eustachian Tube Dysfunction

Long-term Assessment of Balloon Eustachian Tuboplasty for Obstructive Eustachian Tube Disease

LASt-BET
Start date: October 1, 2023
Phase: N/A
Study type: Interventional

To date, more than 130 000 Balloon Eustachian Tuboplasty (BET) procedures have been performed worldwide. This procedure is proposed in case of Obstructive Eustachian Tube Dysfunction (OETD) with or without chronic otitis media. However, the effectiveness of this procedure is still discussed amongst otolaryngologist. Most of studies,were open label prospective studies comparing Eustachian tube function before and after surgical treatment. A recent meta-analysis suggests that BET procedure improves postoperative Eustachian tube function, but high-level evidence is still lacking. In this project, the investigators propose to perform the first blinded randomized controlled trial procedure to assess the changes of Eustachian tube function after BET in a population of subjects with chronic OETD with or without chronic otitis. Prognosis factors of efficacy will be also investigated during the study.

NCT ID: NCT05229380 Not yet recruiting - Clinical trials for Eustachian Tube Dysfunction

Pretympanoplasty Assessment of Patency and Mucociliary Function of Eustachian Tube

Start date: February 28, 2022
Phase:
Study type: Observational

The eustachian tube (ET) performs three primary functions: pressure equalisation between the nasopharyms and middle ear: clearance of mucus from the middle ear, and prevention of sound or fluid reflux from the nasopharynx(1) .In individuals suffering from custachian tube dysunction (ETD), the tube opening may be obstructed(2) resulting in the typical complaints of ear fullness, muffled hearing, or tinnitus(3). Less frequently, the ET may be permanently patulous, resulting in the symptoms of aural pressure or autophony (4). Adequate Eustachian tube function (ETF) is necessary for successful middle ear surgery. Studies of eustachian tube patency have been studied by the Politzer, Valsalva, and Toynbee maneuvers. In other cases it has been accomplished by testing air transport through the eustachian tube by tympanometry, sonotubometry, and air pressure equalization technique. However, these methods do not evaluate the drainage function (5). Saccharin is a nonnutritive sweetener. It has property of being inert to respiratory epithelium that is it does not hamper physiological mucus clearance of sino-nasal mucosa. It can be used to assess mucocilliary function of nasal mucosa, without itself hampering it. The saccharin test seems to provide adequate information of the mucociliary function and patency of the ET (6) . Methylene blue is a chemical compound. It can be used to check patency of (ET). The dye, because of its liquid form, gravitates through the ET to the nasopharynx. So the objective of the dye is to establish the anatomical presence or absence of tube patency.

NCT ID: NCT05222230 Not yet recruiting - Nasal Obstruction Clinical Trials

FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing

FFP3-RAE
Start date: July 23, 2022
Phase: N/A
Study type: Interventional

This is Prospective Basic Science Study whose aims are as follows: 1. To determine the effect of Filtering Facepiece (FFP3M) respirators on eustachian tube function and hearing 2. To evaluate the extent to which FFP3M respirators attenuate speech in decibels The outcome measures are as follows: 1. Changes in baseline pure tone audiometry and tympanometry post intervention. 2. SNOT-22 Questionnaires before and after use of respirator 3. ETDQ7 questionnaire 4. Measurement of speech attenuation in decibels.

NCT ID: NCT03850353 Not yet recruiting - Dizziness Clinical Trials

Obstructive Sleep Apnea Syndrome (OSAS) and Dizziness

OSASDiz
Start date: April 1, 2019
Phase:
Study type: Observational

A total of 400 participants will be recruited: 200 patients with suspected OSAS will be recruited from the sleep clinic (OSAS group), 100 patients diagnosed with dizziness will be recruited from the ENT clinic (Dizziness group). In addition, 100 patients with no dizziness and no evidence for OSAS will be recruited from both the sleep clinic and the ENT clinic (controls). Informed consents will be completed by all participants. ). In order to assess the effect of treatment of OSAS on dizziness -patients with the diagnosis of OSAS will complete validated questionnaires regarding sleep, dizziness and eustachian tube function 3 months following initiation of treatment with CPAP

NCT ID: NCT03322579 Not yet recruiting - Clinical trials for Eustachian Tube Dysfunction

Balloon Dilation of the Eustachian Tube, a Lower Pressure Challenge

Start date: November 2017
Phase: N/A
Study type: Interventional

Balloon dilatation Eustachian tuboplasty has recently become a promising procedure for the treatment of refractory dilatory dysfunction of the Eustachian tube. Eustachian tube (ET) comprises an osseous intratemporal portion and a cartilaginous nasopharyngeal portion. It functions in pressure equalization, middle ear protection and clearance. Eustachian tube function can be adversely affected by viral and bacterial infections, adenoid disease, craniofacial anomalies, neoplasm, genetic predisposition, sinonasal disease and gastroesophageal reflux, leading to Eustachian tube dysfunction. Eustachian tuboplasty by balloon dilation involves the recanalization of the cartilaginous portion of the ET via the nasopharynx with a balloon catheter. This catheter is inflated to multiple atmospheres of pressure for a short amount of time and then removed. The surgical technique, the optimal balloon diameter, pressure or duration of inflation are variable in the literature. Even though the current data shows promising results and a potential benefit of this procedure, further evaluation is still needed in order to establish a higher level of evidence of efficacy and safety.